04.23.2019 Issue 448

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

NICE to Discuss New META Module
at Med-Tech Innovation Expo

Sunday, April 21

NICE is slated to discuss a new module to its Medtech Early Technical Assessment during the upcoming Med-Tech Innovation Expo in Birmingham, U.K.

ISMPP Releases Open Access White Paper

Health Canada Increases Interest in RWE, Encourages Submissions

Article: RWE Can Better Inform Policy Decisions

Magill: Biopharma Must be Open to New Pathways


Bus Info Analyst Senior or Consultant-PS17856

Client Health Economics Consultant (Health Info Cons or Cons Senior)-PS17860

Client Health Economics Consultant(Health Info Cons or Cons Senior)-PS17862

Research Leader - Outcomes Research - Job ID: 205859BR

Industry Spotlight


Conferences Webinars
Future of OCM and Advanced Payment Models in Oncology
    April 25, Chicago, Illinois

WHCC19
    April 28-May 1, Washington, D.C.

15th Annual Specialty Pharmacy Summit
    April 29-May 2, Las Vegas, Nevada

6th Annual FMV Congress
    April 30-May 1, Philadelphia, Pennsylvania

New Drug Pricing Strategies for a Changing Global Market
    April 24

Beyond Drug Development: The Increasing Role of Real-World Data and Real-World Evidence in Medical Research
    April 25

Surmounting Barriers to Adopting Biosimilar Therapies: Strategies for Achieving Goals of the Biologics Price Competition and Innovation Act
    April 30


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Review of Influence: The Institute for Clinical and Economic Review

Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

A Multistakeholder Discussion on Open Access and Medical Publishing

2018 Specialty Drug Trends

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States


 
Special Thanks to Our Partners:
             Truven    
              Evidera    HealthCore    University of FL
Xcenda    OM1    Parexel    Jefferson     Dymaxium
Precision Xtract    Pharmerit    eMax Health    Sciformix
Evidence Partners     ICON
Share this newsletter on social media:

Email Twitter Facebook LinkedIn